These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 19246467)

  • 21. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception.
    Tul N; Novak-Antolic Z
    Prenat Diagn; 2006 Dec; 26(13):1206-11. PubMed ID: 17075793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.
    Krantz D; Goetzl L; Simpson JL; Thom E; Zachary J; Hallahan TW; Silver R; Pergament E; Platt LD; Filkins K; Johnson A; Mahoney M; Hogge WA; Wilson RD; Mohide P; Hershey D; Wapner R;
    Am J Obstet Gynecol; 2004 Oct; 191(4):1452-8. PubMed ID: 15507982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of Rhesus status on first-trimester pregnancy screening markers free beta human chorionic gonadotropin, pregnancy-associated plasma protein-A and nuchal translucency.
    Cowans NJ; Stamatopoulou A; Spencer K
    Prenat Diagn; 2009 May; 29(5):505-7. PubMed ID: 19222026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
    Palomaki GE; Wright DE; Summers AM; Neveux LM; Meier C; O'donnell A; Huang T; Knight GJ; Haddow JE
    Prenat Diagn; 2006 Aug; 26(8):730-9. PubMed ID: 16810709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of maternal smoking on concentrations of the pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of chorionic gonadotropin (beta hCG) in the first trimester of pregnancy].
    Gajewska J; Ceran A; Chełchowska M; Borowski D; Ambroszkiewicz J; Jaczyńska R; Zwoliński J; Laskowska-Klita T
    Przegl Lek; 2008; 65(10):479-82. PubMed ID: 19189527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13+6 weeks of gestation.
    Kagan KO; Frisova V; Nicolaides KH; Spencer K
    Prenat Diagn; 2007 Sep; 27(9):849-53. PubMed ID: 17590888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?
    Goncé A; Borrell A; Fortuny A; Casals E; Martínez MA; Mercadé I; Cararach V; Vanrell JA
    Prenat Diagn; 2005 Dec; 25(12):1156-61. PubMed ID: 16231401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
    Prats P; Rodríguez I; Comas C; Puerto B
    Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester.
    Leung TY; Sahota DS; Chan LW; Law LW; Fung TY; Leung TN; Lau TK
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
    Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes.
    Barrett SL; Bower C; Hadlow NC
    Prenat Diagn; 2008 Jan; 28(1):28-35. PubMed ID: 18186146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First trimester Down syndrome screening: distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A.
    Wøjdemann KR; Larsen SO; Rode L; Shalmi A; Sundberg K; Christiansen M; Tabor A
    Scand J Clin Lab Invest; 2006; 66(2):101-11. PubMed ID: 16537243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18.
    Spencer K; Crossley JA; Green K; Worthington DJ; Brownbill K; Aitken DA
    Prenat Diagn; 1999 Dec; 19(12):1127-34. PubMed ID: 10590430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction.
    Engels MA; Kooij M; Schats R; Twisk JW; Blankenstein MA; van Vugt JM
    Prenat Diagn; 2010 Apr; 30(4):372-7. PubMed ID: 20225232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
    Wald NJ; Barnes IM; Birger R; Huttly W
    Prenat Diagn; 2006 Jun; 26(6):539-44. PubMed ID: 16634123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of maternal systemic lupus erythematosus on first-trimester combined screening for chromosomal abnormalities.
    Heinig J; Steinhard J; Schmitz R; Nofer JR; Kiesel L; Klockenbusch W
    Prenat Diagn; 2007 Jul; 27(7):600-2. PubMed ID: 17437322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.